RecruitingNCT03959748

DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

Sponsor

Polish Cardiology Association

Enrollment

3,000 participants

Start Date

Mar 1, 2018

Study Type

OBSERVATIONAL

Conditions

Pulmonary Arterial Hypertension Chronic Thromboembolic Pulmonary Hypertension

Summary

The BNP-PL is a multicenter, observational study in which patients are prospectively followed in order to investigate clinical course and management of pulmonary hypertension in Poland. All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed in right heart catheterization, will be eligible to participate in the study.

Eligibility

Min Age: 3 Months

Plain Language Summary

Simplified for easier understanding

This is a national registry in Poland collecting data on patients diagnosed with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) — conditions where the blood pressure in the lungs is dangerously high, making the heart work too hard. The registry tracks patient outcomes over time to improve understanding and treatment of these diseases. **You may be eligible if...** - You have been newly diagnosed with PAH or CTEPH after March 1, 2018 - You are older than 3 months at the time of enrollment - Your diagnosis is confirmed by specific pressure measurements in the heart and lung vessels (right heart catheterization) **You may NOT be eligible if...** - Your diagnosis was made before March 2018 - You do not meet the hemodynamic (blood pressure) criteria for PAH or CTEPH - You are unwilling to participate or provide consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Krakowski Szpital Specjalistyczny im. Jana Pawła II

Krakow, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03959748

Related Trials

Spironolactone for Pulmonary Arterial Hypertension

NCT017126201 location

Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions

NCT026916891 location

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

NCT0558771235 locations

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT0721802993 locations

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT0427840451 locations